The Sanger Institute is pleased to announce the availability of
release 5 of Artemis.
Artemis is a free DNA sequence viewer and annotation tool which is
capable of reading and writing complete EMBL and Genbank entries.
The updated user manual and the release itself are available from
the v5 web pages:
http://www.sanger.ac.uk/Software/Artemis/v5/
There have been many bug fixes and improvements since the last
release 2 years ago. The full list of changes is here:
http://www.sanger.ac.uk/Software/Artemis/v5/#changes
More information about Artemis is available from the main Artemis
web page:
http://www.sanger.ac.uk/Software/Artemis/
Artemis is written in Java, and is available for UNIX, GNU/Linux,
Macintosh (MacOS version 9 or version 10) or MS Windows systems.
------------------------------------------------------------------
Description
===========
Artemis is a free DNA sequence viewer and annotation tool that
allows visualisation of sequence features and the results of
analyses within the context of the sequence, and its six-frame
translation. It can read complete EMBL and GENBANK database
entries or sequence in FASTA or raw format. Extra sequence
features can be in EMBL, GENBANK or GFF format.
Artemis distribution
====================
Artemis is distributed under the terms of the GNU General Public
License, hence it is available for free for use by any one for
any purpose.
Further information
===================
More information about Artemis is available at our web site:
http://www.sanger.ac.uk/Software/Artemis/
It contains documentation, screenshots, download and installation
instructions.
Mailing list
============
We welcome contributions to Artemis and suggestions for new
features. An email discussion list has been set up for this
purpose. To join, send a message to 'majordomo at sanger.ac.uk'
with 'subscribe artemis' in the body (not the subject).
Announcements are also sent to this list.
Acknowledgements
================
The development of Artemis is funded by the Wellcome Trust's
Beowulf Genomics initiative, through its support of the Pathogen
Sequencing Unit.
